SCHEMBL6681533

SCHEMBL6681533

O=C(O)C1=CN2C=NC=CC2=CS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30999999 0.63 — —
SCHEMBL9270950 0.51 — —
SCHEMBL6925803 0.51 — —
SCHEMBL12555060 0.49 — —
SCHEMBL10526110 0.49 — —
SCHEMBL9200523 0.48 — —
SCHEMBL29386447 0.45 — —
SCHEMBL669835 0.42 TSHR (0.35) —
Terephthalic Acid SCHEMBL9621388 0.41 TSHR (0.41) —
Bicarbonate SCHEMBL19574 0.37 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014354-A1 1,6-FUSED URACIL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 — — WO claimed
WO-2004014354-A1 1,6-FUSED URACIL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 — — WO disclosed
Send feedback